Stock screener
Filter the covered US universe by sector, size, profitability, dividends and performance. Every screen has its own shareable link — the address bar reflects your filters.
Showing 511–540 of 574 companies · sorted by market cap (low to high)
| Ticker | Company | Sector | Price | Market cap | P/E | Rev growth | Net margin | Div yield | 1y return |
|---|---|---|---|---|---|---|---|---|---|
| DVA | DaVita | Health Care | $234.27 | $15.0B | 19.1 | +6.7% | +5.7% | n/a | +58.9% |
| JAZZ | Jazz Pharmaceuticals | Health Care | $254.87 | $15.9B | 538.0 | +9.2% | +0.7% | n/a | +115.2% |
| BBIO | BridgeBio Pharma, Inc. | Health Care | $82.93 | $16.3B | n/a | +355.2% | -124.4% | n/a | +80.6% |
| THC | Tenet Healthcare | Health Care | $199.02 | $16.7B | 9.8 | +6.6% | +7.8% | n/a | +25.7% |
| MEDP | Medpace | Health Care | $605.82 | $17.4B | 37.7 | +24.2% | +17.2% | n/a | +38.5% |
| NBIX | Neurocrine Biosciences | Health Care | $174.15 | $17.4B | 26.0 | +28.6% | +21.6% | n/a | +30.3% |
| ZBH | Zimmer Biomet | Health Care | $89.65 | $17.4B | 22.9 | +9.2% | +9.1% | +1.0% | -7.9% |
| GH | Guardant Health, Inc. | Health Care | $150.20 | $19.9B | n/a | +39.6% | -40.1% | n/a | +225.9% |
| VTRS | Viatris | Health Care | $17.28 | $20.1B | n/a | +1.6% | -2.0% | +2.8% | +84.4% |
| STE | Steris | Health Care | $210.64 | $20.5B | 26.2 | +8.7% | +13.2% | +1.2% | -6.6% |
| UTHR | United Therapeutics | Health Care | $529.53 | $22.3B | 17.3 | +5.9% | +40.6% | n/a | +73.3% |
| MRNA | Moderna | Health Care | $57.02 | $22.5B | n/a | -30.0% | -143.6% | n/a | +64.5% |
| INSM | Insmed | Health Care | $107.41 | $23.0B | n/a | +115.1% | -144.4% | n/a | +3.6% |
| INCY | Incyte | Health Care | $116.69 | $23.2B | 16.2 | +21.5% | +26.7% | n/a | +68.1% |
| LH | Labcorp | Health Care | $291.02 | $23.8B | 25.3 | +7.3% | +6.7% | +1.0% | +16.2% |
| DGX | Quest Diagnostics | Health Care | $227.90 | $24.9B | 24.3 | +11.0% | +9.1% | +1.6% | +33.7% |
| ROIV | Roivant Sciences | Health Care | $35.10 | $25.3B | n/a | -89.2% | -3629.2% | n/a | +208.2% |
| WST | West Pharmaceutical Services | Health Care | $355.48 | $25.7B | 47.4 | +11.2% | +16.9% | +0.3% | +56.4% |
| MTD | Mettler Toledo | Health Care | $1,331.87 | $26.6B | 30.4 | +6.8% | +21.4% | n/a | +5.9% |
| DXCM | Dexcom | Health Care | $70.48 | $27.3B | 29.3 | +16.1% | +19.3% | n/a | -16.1% |
| RMD | ResMed | Health Care | $191.89 | $27.8B | 18.3 | +10.3% | +27.4% | +1.2% | -29.8% |
| GEHC | GE HealthCare | Health Care | $61.99 | $28.2B | 14.8 | +6.0% | +9.1% | +0.2% | -19.7% |
| VEEV | Veeva Systems | Health Care | $179.58 | $29.2B | 31.0 | +16.3% | +28.4% | n/a | -37.2% |
| ILMN | Illumina, Inc. | Health Care | $196.86 | $29.6B | 34.7 | +1.3% | +19.4% | n/a | +88.2% |
| BIIB | Biogen | Health Care | $200.62 | $30.0B | 21.9 | +1.2% | +13.8% | n/a | +53.2% |
| ZTS | Zoetis | Health Care | $74.57 | $31.2B | 11.8 | +2.4% | +27.8% | +1.6% | -51.4% |
| CNC | Centene Corporation | Health Care | $63.74 | $31.3B | n/a | +17.0% | -3.3% | n/a | +116.7% |
| RPRX | Royalty Pharma | Health Care | $59.02 | $34.0B | 41.1 | +7.8% | +33.9% | +1.6% | +63.9% |
| IQV | IQVIA | Health Care | $207.32 | $34.5B | 24.9 | +7.3% | +8.3% | n/a | +5.9% |
| ALNY | Alnylam Pharmaceuticals | Health Care | $268.74 | $35.3B | 61.1 | +82.6% | +13.5% | n/a | -17.5% |
This is a shareable URL: filters live in the query string — e.g.
/browse?sector=Health+Care, /browse?index=russell2000,
/browse?mktcap=small, /browse?pe_band=under15,
/browse?growth_band=over20, /browse?margin_band=over20,
/browse?div_yield_band=over4, /browse?div_streak=ge10,
/browse?insider=cluster-buy, /browse?holder=blackrock,
/browse?short=elevated.
Combine them, sort with &sort=dividend_yield&dir=desc (or click a column
header), and page with &page=2.
Data: SEC EDGAR (filings) + Finnhub (prices, fundamentals), as of 2026-07-24 close. Prices are delayed daily-close, labelled with their as-of date.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date. Past performance does not indicate future results.